DR-70 tumor marker assay to detect the circulating extracellular matrix complex data

AMDD (Tustin, Calif.) reported results in 237 patients with newly diagnosed disease, and 244 volunteers (smokers and nonsmokers) with no clinical evidence of disease, showing 66 percent sensitivity and 92 percent specificity.

As presented at the International Conference on Human Tumor Markers in New York, blood serum samples collected from the cancer patients contained DR-70 mean levels that were four times higher than in the controls. ...